• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    Cytori Therapeutics, Inc. (CYTX)

    -NasdaqGM
    0.44 Up 0.01(2.33%) Jul 31, 4:00PM EDT
    |After Hours : 0.47 Up 0.03 (5.86%) Jul 31, 4:04PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 7,598   12,196   14,501  
    Cost of Revenue2,940  3,421  4,000  
    Gross Profit 4,658   8,775   10,501  
    Operating Expenses
    Research Development15,105  17,065  13,628  
    Selling General and Administrative21,990  22,389  25,291  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (32,437) (30,679) (28,418)
    Income from Continuing Operations
    Total Other Income/Expenses Net(560)7,946  (310)
    Earnings Before Interest And Taxes(32,997)(22,025)(28,728)
    Interest Expense4,371  3,396  3,386  
    Income Before Tax(37,368)(25,421)(32,114)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(37,368)(26,177)(32,279)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (37,368) (26,177) (32,279)
    Preferred Stock And Other Adjustments(1,169) -   -  
    Net Income Applicable To Common Shares (38,537) (26,177) (32,279)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.